CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Long-Term Outcomes of Patients With Mediastinal Radiation–Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients

Original Research2013 Mar 19;108(5):1071-8.

JOURNAL:Br J Cancer. Article Link

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

van Leeuwen RW, Brundel DH, Neef C et al. Keywords: cardio-oncology; drug interaction; prevalence; oral anticancer drug;

FULL TEXT PDF